![Hongying Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hongying Wang
Corporate Officer/Principal bei China Nuokang Bio-Pharmaceutical, Inc.
Aktive Positionen von Hongying Wang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 23.11.2009 | - |
Karriereverlauf von Hongying Wang
Ehemalige bekannte Positionen von Hongying Wang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. | Corporate Officer/Principal | - | - |
Ausbildung von Hongying Wang
Liaoning University | Undergraduate Degree |
Northeastern University | Masters Business Admin |
Statistik
International
China | 4 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. |
- Börse
- Insiders
- Hongying Wang
- Erfahrung